Ras gene (HRAS, NRAS, and KRAS) has been observed to be mutated and hyper-activated in a significant proportion of cancers. However, mutant Ras remains a challenging therapeutic target. Similarly, inhibition of targets upstream and downstream of Ras has shown limited ...
Read More »Transgenomic Launches New MX-ICP Panels for Liquid Biopsy Detection of RAS and PIK3CA Tumor Mutations
Now Has Six Liquid Biopsy CLIA Cancer Panels that Leverage Exceptional Sensitivity of Multiplexed ICE COLD-PCR to Detect Actionable Mutations in RAS and PIK3CA Genes Relevant to Treatment of Lung and Colorectal Cancers OMAHA, Neb.–(BUSINESS WIRE)–Transgenomic, Inc. (NASDAQ: TBIO) today ...
Read More »